BMM
SYNH

Buffington Mohr McNeal’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Buffington Mohr McNeal’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-81,455
Closed -$5.84M – 121
2022
Q2 		$5.84M Sell
81,455
-1,295
-2% -$94.7K 1.28% 27
2022
Q1 		$6.7M Sell
82,750
-10
-0% -$846 1.27% 28
2021
Q4 		$8.5M Buy
82,760
+2,299
+3% +$221K 1.45% 25
2021
Q3 		$7.04M Buy
80,461
+11,645
+17% +$1.05M 1.35% 28
2021
Q2 		$6.16M Buy
68,816
+386
+0.6% +$32.6K 1.21% 29
2021
Q1 		$5.19M Sell
68,430
-800
-1% -$60.3K 1.11% 29
2020
Q4 		$4.72M Buy
69,230
+2,975
+4% +$185K 1.1% 29
2020
Q3 		$3.52M Sell
66,255
-485
-0.7% -$28.9K 0.93% 31
2020
Q2 		$3.89M Sell
66,740
-1,600
-2% -$86K 1.09% 28
2020
Q1 		$2.69M Buy
68,340
+600
+0.9% +$35.1K 0.9% 32
2019
Q4 		$4.03M Sell
67,740
-1,675
-2% -$90K 1.14% 30
2019
Q3 		$3.69M Buy
69,415
+65
+0.1% +$3.34K 1.13% 30
2019
Q2 		$3.54M Sell
69,350
-395
-0.6% -$18.4K 1.11% 31
2019
Q1 		$3.61M Buy
69,745
+4,600
+7% +$223K 1.16% 29
2018
Q4 		$2.56M Sell
65,145
-1,895
-3% -$88K 1.03% 32
2018
Q3 		$3.46M Sell
67,040
-375
-0.6% -$18.4K 1.19% 29
2018
Q2 		$3.16M Sell
67,415
-1,865
-3% -$77.2K 1.19% 28
2018
Q1 		$2.46M Buy
69,280
+720
+1% +$28.2K 0.94% 34
2017
Q4 		$2.99M Sell
68,560
-980
-1% -$45.8K 1.14% 28
2017
Q3 		$4.05M Buy
69,540
+2,415
+4% +$135K 1.58% 20
2017
Q2 		$3.93M Sell
67,125
-300
-0.4% -$15.6K 1.55% 20
2017
Q1 		$3.09M Buy
67,425
+7,630
+13% +$380K 1.36% 25
2016
Q4 		$3.15M Buy
59,795
+2,695
+5% +$130K 1.2% 23
2016
Q3 		$2.54M Buy
+57,100
New +$2.48M 1.07% 27

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Buffington Mohr McNeal's SYNH Position: Q3 2022 in Review

Buffington Mohr McNeal sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 81,455 shares — an estimated $5.84M sold.

Buffington Mohr McNeal first reported a position in SYNH in Q3 2016 and held it in 24 quarters. The position peaked at $8.5M in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Buffington Mohr McNeal reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Buffington Mohr McNeal sold 81,455 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $5.84M.
  • Buffington Mohr McNeal first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 24 quarters.
  • Buffington Mohr McNeal's Syneos Health, Inc. Class A Common Stock position peaked at $8.5M in Q4 2021.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Buffington Mohr McNeal's 13F filing for Q3 2022, filed 11 Oct 2022.